A study published in Scientific Reports explores the use of red blood cell-derived parameters, particularly red cell distribution width-coefficient of variation (RDW-CV), as a potential tool for differentiating atypical parkinsonian syndromes from Parkinson’s disease.

The research analyzed 30 patients with Parkinson’s disease (PD), 29 with PSP-Richardson’s Syndrome (PSP-RS), 17 with PSP-Parkinsonism Predominant (PSP-P), and 23 healthy controls.Blood samples were evaluated to identify biomarkers that could aid in differential diagnosis.The findings revealed that elevated RDW-CV values were significantly associated with PSP-RS, showing distinct differences compared to other groups.This suggests that RDW-CV could serve as a supplementary diagnostic tool, especially given the overlapping clinical features of PSP and PD.

The study highlights the importance of further research into red blood cell factors in neurodegenerative conditions, offering a non-invasive approach to improve diagnostic accuracy.

The research was conducted at the Medical University of Warsaw and approved by the Bioethical Committee, with ethical standards aligned with the Declaration of Helsinki.